Table 4.
CD133 positive Epithelial Circulating Tumor Cells (E-CTC) and baseline characteristics of patients [n (%)]
| CD133 positive E-CTC | P | ||
|---|---|---|---|
|
| |||
| ≥1 (n=22) | <1 (n=41) | ||
| Age (years) | |||
| ≥60 | 16 (72.73) | 19 (46.34) | 0.045 |
| <60 | 6 (27.27) | 22 (53.66) | |
| Gender | |||
| Male | 14 (63.64) | 27 (65.85) | 0.860 |
| Female | 8 (36.36) | 14 (34.15) | |
| The maximum diameter of the tumor | |||
| ≥5 cm | 13 (59.09) | 14 (34.15) | 0.056 |
| <5 cm | 9 (40.91) | 27 (65.85) | |
| TNM stage | |||
| I-II | 2 (9.09) | 5 (12.20) | 0.709 |
| III-IV | 20 (90.91) | 36 (87.80) | |
| Degree of differentiation | |||
| High | 3 (13.64) | 2 (4.88) | 0.462 |
| Intermediate | 16 (72.72) | 32 (78.05) | |
| Low | 3 (13.64) | 7 (17.07) | |
| Lymphatic metastasis | |||
| Yes | 18 (81.82) | 35 (85.37) | 0.713 |
| No | 4 (18.18) | 6 (14.63) | |
| Distant metastasis | |||
| Yes | 3 (13.64) | 14 (34.15) | 0.080 |
| No | 19 (83.36) | 27 (65.85) | |
| CEA | |||
| <5 ng/mL | 18 (81.82) | 34 (82.93) | 0.912 |
| ≥5 ng/mL | 4 (18.18) | 7 (17.07) | |
| CA-199 | |||
| <35 U/mL | 18 (81.82) | 34 (82.93) | 0.912 |
| ≥35 U/mL | 4 (18.18) | 7 (17.07) | |
CEA, carcinoembryonic antigen.